Implanted port catheters are designed to make treatment easier. For many patients, they’ve caused serious harm instead. If you or a loved one suffered complications linked to a Port-A-Cath device, you may have legal options.
At DV Injury Law, we represent people harmed by defective medical devices. We help patients understand their rights and pursue fair compensation for injuries tied to port-a-cath failures.
At DV Injury Law, we are dedicated to protecting your legal rights when it comes to medical device injuries. If you or a loved one has been affected by the complications from a port-a-cath device, you deserve the opportunity to hold the responsible parties accountable. Our experienced legal team is committed to fighting for justice on your behalf, ensuring you receive the compensation you need to cover medical expenses, lost wages, and the pain and suffering endured. Your health and legal rights are our top priority, and we are here to support you every step of the way.
Lawsuits have been filed against manufacturers, alleging that these companies knew about design defects but failed to warn patients or doctors. Plaintiffs claim the companies prioritized sales over safety, continuing to market devices that carried an unacceptable risk of failure.
The allegations focus on ports made with materials prone to fracturing, poor design choices that increase the risk of migration, and a failure to disclose known complications. Patients argue they would have chosen different treatment options had they been properly informed of the risks. Many lawsuits claim that manufacturers either knew or should have known about the following problems:
Bard’s PowerPort and AngioDynamics products have been specifically named in litigation. Manufacturers have also been accused of ignoring reports of complications from healthcare facilities and patients, continuing production despite documented safety concerns.
The Port-a-Cath litigation continues to move forward with positive momentum for injured patients. The judge issued two recent orders on expert challenges, and both rulings favor plaintiffs. While no defense expert was fully removed, the court blocked key testimony that attempted to shift blame away from the product itself. One defense expert can no longer claim that port-related infections are caused solely by doctors or nurses, rather than by defects or risks associated with the port. That keeps the focus where it belongs, on the safety of the device and the responsibility of the companies that designed and sold it.
Additional orders from the Port judge are likely in the coming days, and we continue to track developments closely. As always, our team stays aggressive in holding manufacturers accountable. If you or a loved one suffered complications linked to an implanted port, we are ready to review your case. Free consultation. No fees unless we win.
Bard PowerPort: 2,463 active cases consolidated in MDL 3081 (Eastern District of Arizona). Jury questionnaires are being finalized for the first six bellwether trials scheduled to begin in March 2026, with additional trials continuing through December 2026.
AngioDynamics: Bellwether trials selected in MDL 3125 (Southern District of California). Litigation progressing through the discovery phase with hundreds of cases pending against AngioDynamics, Inc., and Navilyst Medical, Inc. for defects in Vortex, SmartPort, Xcela, and LifePort systems.
Bard PowerPort: Case numbers topped 2,000 following increased media coverage. Updated discovery schedules and expert disclosure deadlines implemented.
Bard PowerPort: Judge David G. Campbell issued a scheduling order selecting six cases for bellwether trials, focusing on device defects, manufacturing flaws, and failure to warn.
Bard PowerPort: Case numbers exceeded 1,400, representing a surge of approximately 300 cases from March. Common allegations include catheter fractures requiring surgical removal, infections necessitating hospitalization, and cardiac complications from device migration.
AngioDynamics: MDL 3125 established in the Southern District of California, consolidating lawsuits against AngioDynamics, Inc. and Navilyst Medical, Inc. Plaintiffs allege defects including fracture, infection, and failure during normal use, with inadequate warnings.
Bard PowerPort: MDL 3081 established in the Eastern District of Arizona under Judge David G. Campbell. Hundreds of individual lawsuits were consolidated.
